Rituximab

CD20-directed Cytolytic Antibody

Brands

Riabni

Rituximab desired effects:

  • Increased Cellular Death

Rituximab drug classes:

  • CD20-directed Cytolytic Antibody

Rituximab pharmacologic actions:

  • Immunologic Factors
  • Antineoplastic Agents, Immunological
  • Antirheumatic Agents

Rituximab mechanism of action:

  • Antibody-Receptor Interactions
  • CD20-directed Antibody Interactions
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Questions? Call or text: 859-651-7603

LegitScript approved
Copyright © Treatable 2023
Last updated: 4/13/2024, 1:12:24 PM